Article Details

Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results

Retrieved on: 2022-04-16 02:14:28

Tags for this article:

Click the tags to see associated articles and topics

Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results. View article details on hiswai:

Excerpt

... Acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up